Perpetuum launches it’s new brand Ombium, a nutritional supplement line targeting metabolic syndrome risk factors.
![](https://perpetuum.bio/wp-content/uploads/2020/08/p-web-blog06-300x188.png)
vaccines
Polydendritic Nano-Adjuvant
Perpetuum starts pre-clinical stage investigation of it’s proprietary Polydendritic Nano-Adjuvants for novel vaccination strategies.